[Federal Register Volume 66, Number 102 (Friday, May 25, 2001)]
[Notices]
[Page 28920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13204]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Acquired Immunodeficiency Syndrome Research 
Review Committee.
    Date: June 14-15, 2001.
    Open: June 14, 2001, 8:30 am to 9 am.
    Agenda: Reports from various institute staff.
    Place: The Virginian Suites, 1500 Arlington Boulevard, 
Arlington, VA 22209.
    Closed: June 14, 2001, 9 am to 5 pm.
    Agenda: To review and evaluate grant applications.
    Place: The Virginian Suites, 1500 Arlington Boulevard, 
Arlington, VA 22209.
    Open: June 15, 2001, 8:30 am to 9 am.
    Agenda: Reports from various institute staff.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 18, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-13204 Filed 5-24-01; 8:45 am]
BILLING CODE 4140-01-M